MedPath

Assessment of the effect of Vavading powder (Embelia ribes) on Streptococcus mutans in patients undergoing orthodontic treatment with fixed appliances.

Phase 2
Conditions
Health Condition 1: K050- Acute gingivitis
Registration Number
CTRI/2023/03/050838
Lead Sponsor
Dr Anjali Nandanwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Study eligibility will be restricted to those of either gender between the age of 14-30 years and present at least 20 natural teeth.

Subjects in good general and oral health will be enrolled.

Exclusion Criteria

Exclusion criteria included pregnancy or breast feeding, systemic diseases, ongoing or scheduled medical treatment during the study period.

Patients taking medications including antibiotics or anti-inflammatory agents in the month during the study duration will be excluded.

Patients having allergies to oral hygiene formulations, a history of drug or alcohol abuse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath